STRS Ohio’s Fennec Pharmaceuticals FENC Stock Holding History

STRS Ohio’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$67.7K	Buy	6,300 +1,100	+21%	+$8.98K	﹤0.01%	1968
2026 Q1	$32K	Hold	5,200	–	–	﹤0.01%	2012
2025 Q4	$40K	Hold	5,200	–	–	﹤0.01%	2023
2025 Q3	$48.7K	Buy	+5,200	New	+$45K	﹤0.01%	2011
2021 Q2	–	Sell	-15,500	Closed	-$96K	–	2290
2021 Q1	$96K	Hold	15,500	–	–	﹤0.01%	1951
2020 Q4	$115K	Hold	15,500	–	–	﹤0.01%	1862
2020 Q3	$93K	Hold	15,500	–	–	﹤0.01%	1859
2020 Q2	$129K	Buy	+15,500	New	+$115K	﹤0.01%	1735
2019 Q2	–	Sell	-3,300	Closed	-$14K	–	2139
2019 Q1	$16K	Hold	3,300	–	–	﹤0.01%	1982
2018 Q4	$21K	Hold	3,300	–	–	﹤0.01%	1981
2018 Q3	$27K	Hold	3,300	–	–	﹤0.01%	2010
2018 Q2	$34K	Buy	+3,300	New	+$39.1K	﹤0.01%	2023

Other funds holding FENC

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCA

Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

STRS Ohio's FENC Position: Q2 2026 in Review

STRS Ohio increased its Fennec Pharmaceuticals (FENC) stake by 21% in Q2 2026, buying an estimated $8.98K and bringing the position to 6,300 shares worth $67.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1968.

STRS Ohio first reported a position in FENC in Q2 2018 and has held it in 12 quarters since. The position peaked at $129K in Q2 2020. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

STRS Ohio held 6,300 shares of Fennec Pharmaceuticals worth $67.7K as of Q2 2026.
STRS Ohio bought 1,100 Fennec Pharmaceuticals shares in Q2 2026, an estimated $8.98K.
Fennec Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1968 holding.
STRS Ohio first reported a position in Fennec Pharmaceuticals in Q2 2018 and has held it in 12 quarters since.
STRS Ohio's Fennec Pharmaceuticals position peaked at $129K in Q2 2020.
105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.